During South Africa’s COVID-19 hard lockdown, rising star scientist Dr Sandile Cele spent his Christmas holidays in a laboratory. Soon the 35-year-old became the first to successfully grow the beta variant of SARS-CoV-2 in the lab. Biénne Huisman spoke to Cele about how he did this, the string of accolades he received since, and his leap from a modest upbringing to the global scientific stage.
Attending the Forensic DNA Symposium recently held in Cape Town where the vital role of DNA analysis in criminal investigations was highlighted, Sue Segar caught up with Professor Ryan Blumenthal, a senior specialist forensic pathologist at the University of Pretoria. Blumenthal was one of the speakers. He told her more about bearing first-hand witness to death and its causes at the autopsy table and what this can tell us about the society we live in.
During the COVID-19 pandemic, we saw the remarkable power of genomics in helping us keep track of new viral variants. Several scientists argue that Africa should continue to invest in genomics to support disease control and public health. Sue Segar asks what this means in practice and why it is considered so critically important.
So far this year the National Institute for Communicable Diseases has issued reports on three different outbreaks of vaccine-preventable diseases – measles, mumps, and diphtheria. Elri Voigt spoke to local experts about these outbreaks and what it tells us about the country’s immunisation programme and the potential for future outbreaks.
According to recently published estimates from Thembisa, the leading mathematical model of HIV in South Africa, around 7.8 million people, or 13.2% of the population, were living with HIV in South Africa in 2022. Marcus Low looked at the numbers and what they tell us about the state of HIV in South Africa.
Much of South Africa’s public health sector is plagued by long waiting times for surgery, a situation that was made much worse by the COVID-19 pandemic. Now, an inspiring project at Groote Schuur Hospital in Cape Town has reached its target of slashing its backlog by 1 500 surgeries. Elri Voigt reports.
Millions of doses of the Pfizer-BioNtech COVID-19 vaccine procured by the South African government have expired and the shot is largely unavailable to people in the country. Meanwhile, earlier this month, the World Health Organization declared an end to the COVID-19 ‘Public Health Emergency of International Concern’. Adele Baleta asks what all this means for COVID-19 in South Africa.
Round two of the Presidential Health Summit centred on getting closer to realising National Health Insurance, but the question of how to do this remains murky. Ufrieda Ho reports.
South Africa’s new National Strategic Plan for HIV, TB, and STIs 2023-2028 and the country’s TB Recovery Plan necessitate a sharp increase in TB testing and increased enrolment into care, which will require additional spending on testing and medicines. Sihle Mahonga Ndawonde argues that a joint committee should be set up to review and interrogate provincial departments’ resource allocation decisions for the next three years.
The South African TB Recovery Plan was developed to try and reverse the negative effects of the COVID-19 pandemic on the country’s TB response. On World TB Day, authors from TB Proof (a leading TB activist group) assess how the recovery is going and identify four key areas where further intervention is needed.
South Africa’s recently published guidelines for the treatment of tuberculosis (TB) infection have been welcomed by several experts. Among others, the guidelines endorse the use of a three-month course of TB preventive therapy as opposed to the old six-month course. But, while the intention is to roll out the three-month course quite widely, supply constraints may delay things. Tiyese Jeranji reports.
Investment in public health facilities is crucial as the country weathers storms on various fronts – from drought (water shortages) and flooding putting strain on health infrastructure to a harsh economic climate that makes private healthcare unaffordable to more and more people. Mbali Baduza and Matshidiso Lencoasa assess the investments in infrastructure in the budget and what it means for the planned National Health Insurance system.
